251 related articles for article (PubMed ID: 35126461)
1. New Molecular and Organelle Alterations Linked to Down Syndrome Heart Disease.
Venegas-Zamora L; Bravo-Acuña F; Sigcho F; Gomez W; Bustamante-Salazar J; Pedrozo Z; Parra V
Front Genet; 2021; 12():792231. PubMed ID: 35126461
[TBL] [Abstract][Full Text] [Related]
2. Genetics and Molecular Basis of Congenital Heart Defects in Down Syndrome: Role of Extracellular Matrix Regulation.
Mollo N; Scognamiglio R; Conti A; Paladino S; Nitsch L; Izzo A
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769235
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.
Izzo A; Mollo N; Nitti M; Paladino S; Calì G; Genesio R; Bonfiglio F; Cicatiello R; Barbato M; Sarnataro V; Conti A; Nitsch L
Mol Med; 2018 Mar; 24(1):2. PubMed ID: 30134785
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy.
Conti A; Fabbrini F; D'Agostino P; Negri R; Greco D; Genesio R; D'Armiento M; Olla C; Paladini D; Zannini M; Nitsch L
BMC Genomics; 2007 Aug; 8():268. PubMed ID: 17683628
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Dysfunction in Down Syndrome: From Pathology to Therapy.
Tan KL; Lee HC; Cheah PS; Ling KH
Neuroscience; 2023 Feb; 511():1-12. PubMed ID: 36496187
[TBL] [Abstract][Full Text] [Related]
6. Mouse models of Down syndrome: gene content and consequences.
Gupta M; Dhanasekaran AR; Gardiner KJ
Mamm Genome; 2016 Dec; 27(11-12):538-555. PubMed ID: 27538963
[TBL] [Abstract][Full Text] [Related]
7. Genetic dissection of Down syndrome-associated congenital heart defects using a new mouse mapping panel.
Lana-Elola E; Watson-Scales S; Slender A; Gibbins D; Martineau A; Douglas C; Mohun T; Fisher EM; Tybulewicz VL
Elife; 2016 Jan; 5():. PubMed ID: 26765563
[TBL] [Abstract][Full Text] [Related]
8. Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.
Dierssen M; Fructuoso M; Martínez de Lagrán M; Perluigi M; Barone E
Front Neurosci; 2020; 14():670. PubMed ID: 32733190
[TBL] [Abstract][Full Text] [Related]
9. NRIP1/RIP140 siRNA-mediated attenuation counteracts mitochondrial dysfunction in Down syndrome.
Izzo A; Manco R; Bonfiglio F; Calì G; De Cristofaro T; Patergnani S; Cicatiello R; Scrima R; Zannini M; Pinton P; Conti A; Nitsch L
Hum Mol Genet; 2014 Aug; 23(16):4406-19. PubMed ID: 24698981
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for Down syndrome.
Fillat C; Altafaj X
Prog Brain Res; 2012; 197():237-47. PubMed ID: 22541296
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains.
Kuhn DE; Nuovo GJ; Terry AV; Martin MM; Malana GE; Sansom SE; Pleister AP; Beck WD; Head E; Feldman DS; Elton TS
J Biol Chem; 2010 Jan; 285(2):1529-43. PubMed ID: 19897480
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic analysis of Down syndrome.
Patterson D
Hum Genet; 2009 Jul; 126(1):195-214. PubMed ID: 19526251
[TBL] [Abstract][Full Text] [Related]
13. Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts.
Kuhn DE; Nuovo GJ; Martin MM; Malana GE; Pleister AP; Jiang J; Schmittgen TD; Terry AV; Gardiner K; Head E; Feldman DS; Elton TS
Biochem Biophys Res Commun; 2008 Jun; 370(3):473-7. PubMed ID: 18387358
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlation for congenital heart disease in Down syndrome through analysis of partial trisomy 21 cases.
Pelleri MC; Gennari E; Locatelli C; Piovesan A; Caracausi M; Antonaros F; Rocca A; Donati CM; Conti L; Strippoli P; Seri M; Vitale L; Cocchi G
Genomics; 2017 Oct; 109(5-6):391-400. PubMed ID: 28648597
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome research of human amniocytes identifies hub genes associated with developmental dysplasia in down syndrome.
Guo Z; Xiao H; Yang W; Li T; Hao B; Liao S
Aging (Albany NY); 2023 Dec; 15(23):14086-14108. PubMed ID: 38095646
[TBL] [Abstract][Full Text] [Related]
16. Down syndrome--recent progress and future prospects.
Wiseman FK; Alford KA; Tybulewicz VL; Fisher EM
Hum Mol Genet; 2009 Apr; 18(R1):R75-83. PubMed ID: 19297404
[TBL] [Abstract][Full Text] [Related]
17. A non-mosaic transchromosomic mouse model of down syndrome carrying the long arm of human chromosome 21.
Kazuki Y; Gao FJ; Li Y; Moyer AJ; Devenney B; Hiramatsu K; Miyagawa-Tomita S; Abe S; Kazuki K; Kajitani N; Uno N; Takehara S; Takiguchi M; Yamakawa M; Hasegawa A; Shimizu R; Matsukura S; Noda N; Ogonuki N; Inoue K; Matoba S; Ogura A; Florea LD; Savonenko A; Xiao M; Wu D; Batista DA; Yang J; Qiu Z; Singh N; Richtsmeier JT; Takeuchi T; Oshimura M; Reeves RH
Elife; 2020 Jun; 9():. PubMed ID: 32597754
[TBL] [Abstract][Full Text] [Related]
18. Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population.
Li H; Cherry S; Klinedinst D; DeLeon V; Redig J; Reshey B; Chin MT; Sherman SL; Maslen CL; Reeves RH
Circ Cardiovasc Genet; 2012 Jun; 5(3):301-8. PubMed ID: 22523272
[TBL] [Abstract][Full Text] [Related]
19. Transchromosomic cell model of Down syndrome shows aberrant migration, adhesion and proteome response to extracellular matrix.
Delom F; Burt E; Hoischen A; Veltman J; Groet J; Cotter FE; Nizetic D
Proteome Sci; 2009 Aug; 7():31. PubMed ID: 19715584
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to Heart Defects in Down Syndrome Is Associated with Single Nucleotide Polymorphisms in HAS 21 Interferon Receptor Cluster and VEGFA Genes.
Balistreri CR; Ammoscato CL; Scola L; Fragapane T; Giarratana RM; Lio D; Piccione M
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33260695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
